.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01C_SpecificAntirheumaticAgents.M01CB01_SodiumAurothiomalate.SodiumAurothiomalate .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01C_SpecificAntirheumaticAgents.M01CB01_SodiumAurothiomalate.SodiumAurothiomalate| name: | SodiumAurothiomalate | |
| ATC code: | M01CB01 | route: | intramuscular |
| compartments: | 2 | |
| dosage: | 50 | mg |
| volume of distribution: | 0.24 | L |
| clearance: | 2.6 | mL/min |
| other parameters in model implementation | ||
Sodium aurothiomalate is a gold-containing compound formerly used primarily in the treatment of rheumatoid arthritis as a disease-modifying antirheumatic drug (DMARD). It is administered parenterally, usually by intramuscular injection. Its use has largely declined due to safety concerns and the availability of more effective agents.
Pharmacokinetic parameters in adult patients with rheumatoid arthritis. Values are typically reported in clinical studies from patients treated with intramuscular sodium aurothiomalate.